RACHEL ROSE: Open Payments
NPI 1912675422 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 18 payments from 13 companies in 2025. Trend: 2023 $124 · 2024 $0 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $106 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Medtronic, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, TRELEGY ELLIPTA, VYALEV, MINIMED 780G, CAPLYTA, Tlando, Heplisav-B, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
